Diagnostic and Prognostic Performance of N-Terminal ProBNP in Primary Care Patients With Suspected Heart Failure

Gustafsson, 2003, Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function, Eur Heart J, 24, 863, 10.1016/S0195-668X(02)00845-X Vasan, 1999, Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population- based cohort, J Am Coll Cardiol, 33, 1948, 10.1016/S0735-1097(99)00118-7 Fox, 2000, A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community, Eur J Heart Fail, 2, 423, 10.1016/S1388-9842(00)00108-2 Gadsboll, 1989, Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catheterization, Eur Heart J, 10, 1017, 10.1093/oxfordjournals.eurheartj.a059414 Wheeldon, 1993, Echocardiography in chronic heart failure in the community, Q J Med, 86, 17 Cowie, 1997, Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care, Lancet, 350, 1349, 10.1016/S0140-6736(97)06031-5 Nielsen, 2004, N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea, Eur J Heart Fail, 6, 63, 10.1016/j.ejheart.2003.10.003 Wright, 2003, Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial, J Am Coll Cardiol, 42, 1793, 10.1016/j.jacc.2003.05.011 Landray, 2000, Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study, BMJ, 320, 985, 10.1136/bmj.320.7240.985 McGeoch, 2002, Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice, Eur J Heart Fail, 4, 479, 10.1016/S1388-9842(02)00027-2 FDA approval K022516- Elecsys ProBNP. Last accessed: May 11, 2005. Available at: http://www.fda.gov/cdrh/pdf2/k022516.pdf, 2002.In; 2002 Kober, 1994, An echocardiographic method for selecting high risk patients shortly after acute myocardial infarction, for inclusion in multi-centre studies (as used in the TRACE study): trandolapril cardiac evaluation, Eur Heart J, 15, 1616, 10.1093/oxfordjournals.eurheartj.a060443 Sahn, 1978, Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements, Circulation, 58, 1072, 10.1161/01.CIR.58.6.1072 Alam, 1991, The atrioventricular plane displacement as a means of evaluating left ventricular systolic function in acute myocardial infarction, Clin Cardiol, 14, 588, 10.1002/clc.4960140711 Hanley, 1982, The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, 143, 29, 10.1148/radiology.143.1.7063747 Hobbs, 2002, Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations, BMJ, 324, 1498, 10.1136/bmj.324.7352.1498 Bay, 2003, NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function, Heart, 89, 150, 10.1136/heart.89.2.150 Campbell, 2000, Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction, J Card Fail, 6, 130, 10.1016/S1071-9164(00)90015-0 Groenning, 2002, Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations, Am Heart J, 143, 923, 10.1067/mhj.2002.122168 Yamamoto, 1996, Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy, Hypertension, 28, 988, 10.1161/01.HYP.28.6.988 Hammerer-Lercher, 2001, Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction, Clin Chim Acta, 10.1016/S0009-8981(01)00578-2 Pfister, 2004, Use of NT-proBNP in routine testing and comparison to BNP, Eur J Heart Fail, 6, 289, 10.1016/j.ejheart.2003.12.012 Hunt, 1997, Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): a new marker of cardiac impairment, Clin Endocrinol (Oxf), 47, 287, 10.1046/j.1365-2265.1997.2361058.x McClure, 1998, Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care, BMJ, 317, 516, 10.1136/bmj.317.7157.516 Takeda, 2004, Effects of carvedilol on plasma B-type natriuretic peptide concentration and symptoms in patients with heart failure and preserved ejection fraction, Am J Cardiol, 94, 448, 10.1016/j.amjcard.2004.05.004 Murdoch, 1997, Brain natriuretic peptide is stable in whole blood and can be measured using a simple rapid assay: implications for clinical practice, Heart, 78, 594, 10.1136/hrt.78.6.594 Nielsen, 2001, Cross sectional study estimating prevalence of heart failure and left ventricular systolic dysfunction in community patients at risk, Heart, 86, 172, 10.1136/heart.86.2.172 Maron, 2004, Usefulness of B-type natriuretic peptide assay in the assessment of symptomatic state in hypertrophic cardiomyopathy, Circulation, 109, 984, 10.1161/01.CIR.0000117098.75727.D8 Weber, 2004, Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis, Am J Cardiol, 94, 740, 10.1016/j.amjcard.2004.05.055 Cowie, 2003, Clinical applications of B-type natriuretic peptide (BNP) testing, Eur Heart J, 24, 1710, 10.1016/S0195-668X(03)00476-7 Gardner, 2003, N-terminal pro-brain natriuretic peptide: a new gold standard in predicting mortality in patients with advanced heart failure, Eur Heart J, 24, 1735, 10.1016/j.ehj.2003.07.005 Groenning, 2004, Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population, Heart, 90, 297, 10.1136/hrt.2003.026021